Dual CD4-based chimeric antigen receptor T-cell therapy reduces HIV pathogenesis

Study demonstrates the enhanced therapeutic potency of dual CD4-based chimeric antigen receptor T-cell treatment with the potential to treat HIV infection.
Study demonstrates the enhanced therapeutic potency of dual CD4-based chimeric antigen receptor T-cell treatment with the potential to treat HIV infection.